GEO Publications
Handout
NAR 2024 (latest)
NAR 2002 (original)
All publications
FAQ
MIAME
Email GEO
NCBI
>
GEO
>
Accession Display
Not logged in |
Login
GEO help:
Mouse over screen elements for information.
Scope:
Self
Platform
Samples
Series
Family
Format:
HTML
SOFT
MINiML
Amount:
Brief
Quick
GEO accession:
Sample GSM31102
Query DataSets for GSM31102
Status
Public on Oct 28, 2004
Title
CBCD34_setF_4hr
Sample type
RNA
Source name
umbilical cord blood CD34+ cells, 4 hrs TGF-beta treatment
Organism
Homo sapiens
Extracted molecule
total RNA
Description
Total RNA
RNeasy extraction
Two rounds amplification (RT+IVT) Ambion MessageAmp kit
Submission date
Sep 28, 2004
Last update date
May 27, 2005
Contact name
Agnes Viale
E-mail(s)
[email protected]
Phone
212 639 3031
Fax
212 717 3053
Organization name
Memorial Sloan Kettering Cancer Center
Department
Molecular Biology
Lab
Genomics Core Laboratory
Street address
1275 York Avenue
City
New York
State/province
NY
ZIP/Postal code
10021
Country
USA
Platform ID
GPL96
Series (1)
GSE1802
CBCD34-TGFbeta targets
Data table header descriptions
ID_REF
VALUE
signal intensity
ABS_CALL
absolute detection call where P=present, A=absent, and M=marginal
DETECTION P-VALUE
confidence on call
Data table
ID_REF
VALUE
ABS_CALL
DETECTION P-VALUE
AFFX-BioB-5_at
219.1
P
0.000446
AFFX-BioB-M_at
465.4
P
0.00006
AFFX-BioB-3_at
277.8
P
0.000052
AFFX-BioC-5_at
624.6
P
0.00007
AFFX-BioC-3_at
530.8
P
0.00006
AFFX-BioDn-5_at
547.4
P
0.000052
AFFX-BioDn-3_at
2786.5
P
0.000044
AFFX-CreX-5_at
5522.2
P
0.000044
AFFX-CreX-3_at
8068.7
P
0.000044
AFFX-DapX-5_at
4.3
A
0.327065
AFFX-DapX-M_at
7.5
A
0.52976
AFFX-DapX-3_at
1.3
A
0.949771
AFFX-LysX-5_at
2.7
A
0.804734
AFFX-LysX-M_at
5.8
A
0.749204
AFFX-LysX-3_at
3.9
A
0.617401
AFFX-PheX-5_at
0.7
A
0.994435
AFFX-PheX-M_at
0.9
A
0.916408
AFFX-PheX-3_at
39.5
A
0.131361
AFFX-ThrX-5_at
1.1
A
0.876428
AFFX-ThrX-M_at
3.2
A
0.5
Total number of rows:
22283
Table truncated, full table size
581 Kbytes
.
Supplementary data files not provided
|
NLM
|
NIH
|
GEO Help
|
Disclaimer
|
Accessibility
|